Viatris
  • About Us
    • Our Story
    • Our Leadership
    • Our Culture
    • CSR
    • Global Healthcare Gateway
    • Public Policy
    • Document Library
    • Contact us
  • Products
    • Product Details
  • Newsroom
    • Australia News
    • Global Press Releases
    • Stories and Viewpoints
  • Careers
    • Working at Viatris
    • Diversity and Inclusion
    • Career FAQ
  • Investors
    • Events and Presentations
    • Financials and Filings
    • Stock Information
    • Shareholder Toolkit
    • Investor FAQs
Show Menu
Change LocationAU
Choose Your Location
Global Visit our Corporate site
  • Australia
    • Austria
      • Belgium
        • Dutch
        • French
      • Brazil
        • Bulgaria
          • Canada
            • English
            • French
          • China
            • Croatia
              • Czech Republic
                • Denmark
                  • Estonia
                    • Finland
                      • France
                        • GermanyGermany
                          • Greece
                            • Hong Kong
                              • Hungary
                                • India
                                  • Ireland
                                    • Italy
                                      • Japan
                                        • Korea
                                          • Latvia
                                            • Lithuania
                                              • Malaysia
                                                • Mexico
                                                  • Netherlands
                                                    • New Zealand
                                                      • Norway
                                                        • Philippines
                                                          • Poland
                                                            • Portugal
                                                              • Romania
                                                                • Russia
                                                                  • Saudi Arabia
                                                                    • Arabic
                                                                    • English
                                                                  • Serbia
                                                                    • Slovakia
                                                                      • Slovenia
                                                                        • South Africa
                                                                          • Spain
                                                                            • Sweden
                                                                              • Switzerland
                                                                                • German
                                                                                • French
                                                                              • Taiwan
                                                                                • Thailand
                                                                                  • Türkiye
                                                                                    • United Kingdom
                                                                                      • United States

                                                                                          Leaving the Viatris site

                                                                                          You are now leaving the Australian Viatris page for a Viatris affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Viatris affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site, and unaffiliated third party sites may also be subject to their own terms and data protection notices and practices. Third party sites may be subject to the laws, regulatory requirements, data protection requirements, and medical practices of another country. Accordingly, the information provided therein may not be suitable for use in your country.

                                                                                          Continue
                                                                                          Cancel

                                                                                          Localised information for

                                                                                          The page you are about to visit contains information about Viatris that is specific to . Regulatory requirements, data protection requirements and practices or medical practices may differ between countries, and therefore the information provided on this page may not be suitable for use in all countries.

                                                                                          Cancel
                                                                                          Continue to country page

                                                                                          Localized information for Australia

                                                                                          The page you are about to visit contains information about Viatris that is specific to Australia. Regulatory requirements, data protection requirements and practices or medical practices may differ between countries, and therefore the information provided on this page may not be suitable for use in all countries.

                                                                                          Cancel
                                                                                          Confirm

                                                                                          Leaving this page

                                                                                          You are now leaving the Australia Viatris page for a Viatris affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Viatris affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.
                                                                                          Cancel
                                                                                          Continue
                                                                                          1. ←
                                                                                          2. Newsroom
                                                                                          3. Australia News
                                                                                          4. New state-of-the art addition expands one of Australia's medicine facilities

                                                                                          New state-of-the art addition expands one of Australia's medicine facilities

                                                                                          Viatris Australia announces the opening of new critical medication production lines at its Carole Park manufacturing site with a focus on sustainable practices.

                                                                                          Brisbane, 16 August 2022 – Viatris Australia announces the opening of its new production lines to increase and support resilient capacity for the supply of critical medications to Australian patients. As one of the leading suppliers of medicines to the PBS by volume, the launch of a new stand-alone manufacturing suite at Viatris’ facility in Carole Park, Queensland will allow Viatris to produce approximately an additional 1 billion doses of medicine every year to support the secure supply of medicines. The site currently produces approximately three billion doses of medicine every year.

                                                                                          The suite has been developed with a grant of up to one million dollars from the Federal Government supporting its Sovereign Manufacturing Capability Plan, aiming to increase supply chain resilience across the healthcare systems in general and the pharmaceutical supply chain.

                                                                                          Country Manager of Viatris Australia, Sylvain Vigneault said, “Maintaining a reliable supply of medicines is always critical, but even more so – and often more challenging – during global pandemics. By combining our local manufacturing expertise with our strong global network of manufacturing facilities, Viatris helps get medicines to Australian patients whenever and wherever they may need them.”

                                                                                          The investment in the manufacturing site at Carole Park will support the supply of critical medicines and increase agility to respond to changing healthcare needs. It also ensures Carole Park is a key part of our global, diverse and flexible supply chain.

                                                                                          “Australia needs to have a plan to secure supplies of medications. By enhancing the capacity to manufacture medicines at Carole Park, Viatris Australia is leading the sector to be a source of stability in a world of evolving healthcare needs,” said Mr Vigneault.

                                                                                          Additionally, the Viatris manufacturing site is one of the biggest employers in the region, employing over 600 people across STEM industries. The new suite will look to expand the workforce by creating up to 25 manufacturing jobs and 10 scientific and engineering support jobs. This will further support the local economy and the people of Queensland.

                                                                                          The new addition is welcome news to Head of Operations at Viatris Australia, Rob Elliot, who has been part of the development of the site for over 38 years.

                                                                                          “We have been manufacturing medicines at Carole Park for 40 years. Our continued investment in the manufacturing site serves the local community, ensuring that the skills and expertise required for healthcare manufacturing will grow and be retained in Australia. We are particularly proud that the site has been developed in line with Viatris’ commitment to reduce its environmental impact and promotes sustainable and responsible operations,” said Mr. Elliot.

                                                                                          Viatris aims to reduce absolute Scope 1 and Scope 2 greenhouse gas (GHG) emissions by 42% by 2030 from a 2020 baseline. These near-term targets have been submitted to the Science Based Target initiative (SBTi) for review and validation. The Carole Park site is supporting Viatris’ efforts to reduce GHG and these new production lines are designed to operate with greater efficiency reducing the amount of energy to manufacture products. The site has already replaced traditional lighting with LED lighting, has recycled approximately 250 tonnes of material and shifted to capture approximately 15 per cent of the water used at the site through rainwater.

                                                                                          By the end of November, it is anticipated that the production lines will be in use and begin supplying medicines across Australia and to other countries.

                                                                                          END

                                                                                          Media Contact:

                                                                                          Alicia Campagnolo
                                                                                          Communications Manager, Viatris Australia and New Zealand
                                                                                          M: 0449 902 687
                                                                                          E: alicia.campagnolo@viatris.com

                                                                                          Notes to the Editor:

                                                                                          About Viatris

                                                                                          Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognised brands, complex generic and branded medicines, a portfolio of biosimilars and a variety of over-the-counter consumer products. With approximately 37,000 colleagues globally, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube.

                                                                                          • Viatris Privacy Notice
                                                                                          • Viatris Cookie Notice
                                                                                          • Terms of Use
                                                                                          • California Supplemental Disclosure
                                                                                          • Viatris’ Policy Statement Regarding Slavery and Human Trafficking
                                                                                          • Contact Us
                                                                                          • Viatris Privacy Notice
                                                                                          • Viatris Cookie Notice
                                                                                          • Terms of Use
                                                                                          • Contact Us
                                                                                          • California Supplemental Disclosure
                                                                                          • Viatris’ Policy Statement Regarding Slavery and Human Trafficking
                                                                                          • About Us
                                                                                          • Products
                                                                                          • Careers
                                                                                            • linkedin
                                                                                            • instagram
                                                                                            • twitter
                                                                                            • youtube

                                                                                            Visit our corporate site

                                                                                            Viatris

                                                                                            Visit Viatris Connect

                                                                                            © 2025 Viatris Inc. All Rights Reserved. VIATRIS, the Viatris Logo, GLOBAL HEALTHCARE GATEWAY,PARTNER OF CHOICE and the Global Healthcare Gateway logo are Viatris Company trademarks.